Interestingly, our results showed that the expression levels of CDK4, CDK6, and cyclin D1 in CRC cells were visually reduced after POLQ knockdown, which suggested that POLQ knockdown affects the cell cycle process and may be a potential factor in cancer therapy. The gene discussed is POLQ; the disease is colorectal carcinoma.